3D Printing Financials: 3D Systems, Prodways, and Align Build on Positive Momentum - 3DPrint.com
3D Systems reported Q2 revenue of $94.6M, flat YoY, with healthcare up 6.8% and aerospace/defense and data center infrastructure each growing over 20%. Adjusted EBITDA loss narrowed to $0.8M. It expects Q3 revenue of $96M to $99M. Prodways posted Q2 revenue of €10.5M (+5% YoY) and plans a €20M buyback. Align Technology reported record Q2 revenue of just over $1.05B (+4.3%), with clear aligner revenue up 8.2% and 2026 revenue growth guidance of 3% to 4%.
How this was made
The 30-second read
Why it matters
For DDD, the key trade inputs are segment growth (healthcare, aerospace/defense, data center) and a specific Q3 revenue range. For ALGN, the key inputs are record revenue and shipments alongside a scanner mix shift (leasing/lower-priced models). For Prodways, the key inputs are a return to growth after a software divestiture and a defined €20M share buyback program.
Market read
This is a multi-company earnings update with concrete quarterly results, segment drivers, and guidance/capital return details that can influence near-term positioning in additive manufacturing and digital dentistry exposure.
What to watch
The article highlights growth but does not quantify margins, cash flow, or backlog; traders may need to verify whether profitability and order intake are improving sustainably beyond revenue.
Background
The piece frames three additive manufacturing-adjacent companies’ latest earnings as evidence the market is moving forward, with healthcare and select industrial niches leading.
Ticker impact
3D Systems reported Q2 revenue of $94.6M, healthcare up 6.8%, and guided Q3 revenue of $96M to $99M.
Likely positive bias for DDD into/after the earnings window, with follow-through tied to whether Q3 range is viewed as credible.
The article provides multiple segment growth datapoints and a specific Q3 revenue guide, which are actionable for traders even without the stock’s reaction magnitude.
Align Technology posted record Q2 revenue of just over $1.05B, clear aligner revenue up 8.2%, and nearly 692,000 case shipments.
Moderately positive for ALGN, with investors focusing on whether scanner leasing adoption is a temporary revenue headwind.
The article includes hard quarterly results, shipment records, and a largely unchanged 2026 outlook, which can drive estimates and sentiment.
Market effects
Supports the view that healthcare and certain industrial end markets (aerospace, defense, data center infrastructure) are stabilizing or growing within additive manufacturing.
Limited direct regional read-through; includes a US-listed name (DDD, ALGN) and a France-listed name (Prodways) with Europe-specific capital return (buyback).
Reinforces global demand narratives around medical applications and AI data-center infrastructure as incremental drivers for metal AM and related workflows.
Counterpoint
Scanner-related revenue softness at Align and uneven industrial recovery could mean the apparent momentum is mix-driven rather than broad-based demand strength.
Key entities
- public_company3D Systems
Reported Q2 revenue of $94.6M, healthcare growth, and guided Q3 revenue of $96M to $99M; CEO stepping down was mentioned as occurring a day after earnings.
- public_companyProdways
Reported Q2 revenue of €10.5M, returned to growth after 2025 difficulties, and announced a €20M share buyback program.
- public_companyAlign Technology
Reported record Q2 revenue of just over $1.05B, clear aligner growth, and nearly 692,000 case shipments; scanner revenue declined due to leasing/lower-priced adoption.
